BORIO LUCIANA sold $60K of PODD

BORIO LUCIANA sold 418 shares of INSULET CORP (PODD) at $143.27 on 2026-06-03.

Original reporting
SEC EDGAR · BORIO LUCIANA
Published Jun 4, 2026, 8:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 4, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PODD
Neutral
medium confidence
Mentioned
$PODD
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PODDNeutralLow
01

Why it matters

The event updates insider ownership records but does not provide new company performance, guidance, or deal information.

02

Market read

Traders may monitor for follow-on insider selling or other catalysts, but this specific filing alone is unlikely to drive sustained repricing.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-scheduled personal liquidity needs; without broader insider activity, signal is limited.

Relevance 5/10Novelty 6/10Timing: Filed after-hours/late day (2026-06-04 16:23 ET) following the 2026-06-03 sale.

Background

This is an SEC Form 4 insider transaction disclosure (director selling shares).

Company-level read

Ticker impact

$PODDNeutralMedium confidence
Context

Insider Form 4 shows Insulet director Luciana Boro sold 418 shares in an open-market transaction on 2026-06-03.

Expected impact

Likely minimal; any reaction should fade quickly unless accompanied by other negative news.

Evidence & confidence

The filing is a routine insider transaction with no 10b5-1 plan stated; however, the disclosed size (~$60K) is small relative to typical market cap and lacks new operating information.

Market effects

No clear read-through to medical device/insulin delivery peers from a single small insider sale.

None.

None.

Counterpoint

The absence of an identified 10b5-1 plan could be interpreted as discretionary selling, but the disclosed value is still modest.

Key entities

  • Insulet Corp

    Company whose director sold shares via an open-market transaction disclosed on Form 4.

  • BORIO LUCIANA

    Director who sold 418 shares at $143.27 on 2026-06-03.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PODDMedAI 8/10

Insulet Corp (PODD) Q3 2026 Earnings Call Highlights: Revenue Up 19%, EPS Jumps 60%

Insulet Corp (PODD) reported Q3 2026 revenue up 19% and EPS up 60%. US new customer starts were flat, while global growth was low single-digits. The company expects 2027 growth to be modestly below mid-teens due to tougher comparisons and increased competition. Free cash flow for 2026 is expected to be $275 million. PBM negotiations for 2027 are ongoing, creating some uncertainty. The company plans to launch Omnipod 6 in 2027, with features aimed at improving clinical outcomes and lifestyle fit.